ECI Therapeutics

ECI develops products to synergistically combine the tissue-repairing benefits of human platelet-rich plasma-derived growth factors and the sustained release action of hyaluronic acid or chitosan. From company website Source · Oct 12, 2026

Keywords: ophthalmology graft-versus-host disease